Robert Borotkanics

profile image

Senior Research Fellow






  • Australian Health Review, Associate Editor, 2019 - present
  • New Zealand Statistical Association
  • Australian Healthcare and Hospitals Association



Dr Borotkanics’ interdisciplinary expertise applies a range of biostatistics approaches to a variety of biomedical, clinical, health services research and public health research collaborations.  His current research collaborations involve multiple cohort studies, including surgical outcomes, pain management services and health behaviours in youth.  He additionally is active in a drug equivalence clinical trial.  All these studies he serves as the lead in biostatistics. His previous studies as lead in biostatistics are various, including multiple clinical trials and cohort studies: late stage renal management, prostate cancer, breast cancer, orthopaedics and child health.  He works and has worked in collaborations across the United States, Australia and the European Union.

Dr Borotkanics has served in numerous capacities over his career.  He was in the civil service at the US Agency for Healthcare Research and Quality (AHRQ).  He served as a government project officer on a US Institute of Medicine report, “Patient Safety: Achieving a New Standard for Care.”  Dr. Borotkanics is a former Guest Researcher at the US National Institutes of Health, within the National Institutes of Health’s National Institute on Alcohol Abuse and Alcoholism.  He was also a US National Institutes of Health’s of Informatics Research Fellow. Dr. Borotkanics is actively involved in toxicity testing policy.


  • DrPH, Johns Hopkins Bloomberg School of Public Health 2014
  • MS, Johns Hopkins School of Medicne 2010
  • MPH, Johns Hopkins Bloomberg School of Public Health 2007


  • Director’s Award for Merit, Agency for Healthcare Research and Quality, US Department of Health and Human Services, 2010
  • Secretary’s Award for Distinguished Service, US Department of Health and Human Services 2003

Teaching Areas:

Doctoral candidates and Master’s Studies

Convene the School of Sport and Recreation postgraduate, biostatistics clinic and workshop training program.  Carry out informal consultations across faculty.

Individuals interested in doctoral training (PhD or Doctor of Health Sciences) or Master’s studies are encouraged.  Current students are involved in various topics, with strong quantitative emphasis.  The emphasis of the training I provide is applied statistics and biostatistics, with an emphasis is on training to provide biostatistics support to observational and clinical studies.  The overriding goal is to provide quantitative vigour in informing clinical and public health policy decisions.

Active students:

  1. Enora Le Flao, doctoral candidate. Topic: Head impacts monitoring in sports: Development of new methods for the analysis of acceleration signals.
  2. Rebecca Mowat, doctoral candidate. Topic: The effectiveness of a three-week multidisciplinary chronic pain programme.

2019 completions:

  1. Sharita Meharry, Master’s (First Class Honours), 2019.  Thesis: Audit of Grade 3 Breast Cancer in New Zealand Women.


Research Areas:


  • Public Health (Health Behaviour and Environmental Health Sciences)
  • Health Services (Safety and Quality)
  • Toxicology (Alternatives to Animal Testing)
  • Risk Assessment (Chemicals and Drug Products)
  • Cancer (Reproductive and Liver)
  • Clinical Trials (Drug Equivalence and Biomarkers)


  • Observational study analyses (cohort, case-control and cross-sectional)
  • Frailty models
  • Motifs and dynamic models


Selected publications, most recent five years:

  1. Koelmeyer LA, Borotkanics RJ, Alcorso J, Prah P, Winch CJ, Nakhel K, Dean CM, Boyages J. Early surveillance is associated with less incidence and severity of breast cancer–related lymphedema compared with a traditional referral model of care. Cancer. 2019;125(6):854-62.
  2. You Y, Joseph C, Wang C, Gupta V, Liu S, Yiannikas C, Chua BE, Chitranshi N, Shen T, Dheer Y, Invernizzi A, Borotkanics R, Barnett M, Graham SL, Klistorner A. Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease. Brain. 2019;142(2):426-42.
  3. McKenzie CR, Whatman C, Brughelli M, Borotkanics R. The effect of the NetballSmart Dynamic Warm-up on physical performance in youth netball players. Physical Therapy in Sport. 2019;37:91-8.
  4. Frutiger M, Taylor T, Borotkanics RJ. Self-reported Non-Specific Neck Pain (NSNP) is associated with presenteeism and biopsychosocial factors among office workers. International Journal of Workplace Health Management. 2019;12(4):214-227.
  5. Wormgoor SG, Dalleck L, Zinn C, Borotkanics R, Harris N. High-intensity Interval Training is Equivalent to Moderate-intensity Continuous Training for Short-and Medium-term Outcomes of Macro-and Microvascular Complication Markers in Men with Type 2 Diabetes. Frontiers in endocrinology. 2018;9:475.
  6. Rice D, Kluger M, McNair P, Lewis G, Somogyi A, Borotkanics R, Barratt DT, Walker M. Persistent postoperative pain after total knee arthroplasty: a prospective cohort study of potential risk factors. British Journal of Anaesthesia. 2018;121(4):804-12.
  7. Lam TC, Borotkanics R, Hseih F, Salinas J, Boyages J. Immediate two-stage prosthetic breast reconstruction failure: radiation is not the only culprit. Plastic and Reconstructive Surgery. 2018;141(6):1315-24.
  8. Taylor L, Kerse N, Klenk J, Borotkanics R, Maddison R. Exergames to Improve the Mobility of Long-Term Care Residents: A Cluster Randomized Controlled Trial. Games for health journal. 2018;7(1):37-42.
  9. Shore ND, Pieczonka CM, Henderson RJ, Bailen JL, Beebe-Dimmer JL, Ruterbusch JJ, Saltzstein DR, Concepcion RS, Borotkanics R, Levin R, Wissmueller S. Evaluation of the MiCheck MIA test performance in differentiating aggressive from non-aggressive prostate cancer: The MiCheck-01 prospective trial. Journal of Clinical Oncology. 2018;36(6_suppl): TPS152-TPS152.
  10. Borotkanics R, Rowe C, Georgiou A, Douglas H, Makeham M, Westbrook J. Changes in the profile of Australians in 77 residential aged care facilities across New South Wales and the Australian Capital Territory. Australian Health Review. 2018;41(6):613-20.
  11. Wang GY, Taylor T, Sumich A, Merien F, Borotkanics R, Wrapson W, Krägeloh C, Siegert RJ. Associations between immunological function and memory recall in healthy adults. Brain and cognition. 2017;119:39-44.
  12. Borotkanics R, Locke P. EPAs methodology to inform TSCA pre-manufacturing notification decision-making: a critical analysis based on chemicals regulated by consent order. International Journal of Risk Assessment and Management. 2017;20(1-3):226-39.
  13. Sen Y, Qian Y, Koelmeyer L, Borotkanics R, Ricketts R, Mackie H, Lam TC, Shon KH, Suami H, Boyages J. Breast Cancer-Related Lymphedema: Differentiating Fat from Fluid Using Magnetic Resonance Imaging Segmentation. Lymphatic research and biology. 2017;16(1):20-7.
  14. McCaughey E, Borotkanics R, Gollee H, Folz R, McLachlan A. Abdominal functional electrical stimulation to improve respiratory function after spinal cord injury: a systematic review and meta-analysis. Spinal cord. 2016;54(9):628.
  15. McCaughey E, Purcell M, McLean A, Fraser M, Bewick A, Borotkanics R, Allan DB. Changing demographics of spinal cord injury over a 20-year period: a longitudinal population-based study in Scotland. Spinal Cord. 2016;54(4):270.
  16. Borotkanics R, Trush M, Locke P. Analysis of ToxCast Data—In Vitro and Physiochemical Properties—In the Accurate Classification of Chemicals That Induce Hepatocarcinogenesis In Vivo. Applied In Vitro Toxicology. 2015;1(4):262-75.
  17. Borotkanics R, Lehmann H. Network motifs that recur across species, including gene regulatory and protein–protein interaction networks. Archives of toxicology. 2015;89(4):489-99.